CLINICAL_TRIALS
withdrawal
· 2020-11-13
Clinical Trial Update: Aspirin (ASA) Therapy and Preeclampsia Prevention [Phase 4]
Summary
A Phase 4 trial studying aspirin therapy for preeclampsia prevention has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Tennessee | Conditions: Preeclampsia | Phase 4 | Status: WITHDRAWN